Iftikhar Kullo

Prof Iftikhar Kullo

Cardiovascular Disease, College of Medicine, Mayo Clinic

The main focus of Dr. Kullo's laboratory is to improve the ability to predict adverse cardiovascular events in asymptomatic individuals using genetic susceptibility markers, circulating biomarkers and measurements of arterial function.

  • Member, Clinical and Integrative Cardiovascular Science Study Section, Center for Scientific Review, National Institutes of Health, 2014-present
  • Co-chair, Return of Results/Ethical, Legal and Social Implications working group, eMERGE Network, 2011-present
  • Chair, Genomics, Translational Biology and Observational Epidemiology (GTOE) Study Section, American Heart Association, 2013
  • Travel grant recipient, American Society for Clinical Investigation-Association of American Physicians Joint Meeting, 2007
  • New investigator award recipient, Department of Medicine, Mayo Clinic, 2006



Featured Speakers



evidera excelra genrubix signet at big data stemtrak

The event is a good opportunity for industry to come together and identify ways to understand and utilize big data in the advancement of patient care.

Dr Mark Roche, CEO, Avanti iHealth

Show the sponsors

Vote who is making waves in the industry!

Phacilitate will gather influencers and industry innovators together from across healthcare, academia, Big Pharma, government and technology innovators into an ebook. Find out more